Questions and Answers for the December 2021 Gold Members' Teleconference.
By Brian Dennehy
Access Level | member
2021 Market Recap - Mania Chronicles - Interest Rates - US Focus - 2022 Outlook - Market Update
Here we look at the 20 Best and Worst funds this year. The wide range of funds emphasises how important fund selection is to your investing success.
Access Level | public
In this blog, we look at the winning sectors for 2021, as well as those who had a more torrid time.
By Ben Debney
This analysis is more interesting this year than in prior years. We look at the performance of global stock markets in three different ways:
By Ruairi Dennehy
The coronavirus pandemic has made biotechnology front page news. The arrival of multiple vaccines in record time has starkly highlighted how innovative – and versatile – the sector can be.
By Guest Blog
Last week Saxo Bank released their “10 Outrageous Predictions for 2022”. These predictions are ‘unlikely’ events which could cause considerable disruption in markets, and are particularly relevant with the unpredictable COVID-19 crisis in mind.
In the last two years we have all become more appreciative of not just the work of our NHS, but also the extraordinary scientists who typically sit in the background. It is time for us to revisit the biotech funds.
Stirring inflation, policy changes, COVID unlock, geo-political tensions… what does all of this mean for a typically cautious investor?
This week we review our Dynamic Global Portfolio. We explore how the portfolio is made and its performance, both short term and long term.